Search details
1.
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2.
Rheumatology (Oxford)
; 63(2): 534-541, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37228039
2.
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Respir Res
; 25(1): 151, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38561798
3.
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.
J Infect Dis
; 228(12): 1667-1674, 2023 12 20.
Article
in English
| MEDLINE | ID: mdl-37565522
4.
Mapping frailty in people living with HIV: A nationwide study in Greece.
HIV Med
; 24(2): 170-179, 2023 02.
Article
in English
| MEDLINE | ID: mdl-35840121
5.
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study.
Eur J Clin Microbiol Infect Dis
; 42(7): 843-852, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37133639
6.
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors.
HIV Med
; 23(11): 1143-1152, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36258653
7.
Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.
J Med Virol
; 94(3): 1050-1059, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34708878
8.
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial.
Crit Care
; 26(1): 183, 2022 06 18.
Article
in English
| MEDLINE | ID: mdl-35717241
9.
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Am J Respir Crit Care Med
; 203(2): 202-210, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-32757963
10.
Filamentous Fungal Keratitis in Greece: A 16-Year Nationwide Multicenter Survey.
Mycopathologia
; 187(5-6): 439-453, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36178544
11.
Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece.
Sex Transm Infect
; 97(3): 232-237, 2021 05.
Article
in English
| MEDLINE | ID: mdl-32561553
12.
Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment.
Eur J Clin Microbiol Infect Dis
; 40(1): 219-224, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32729059
13.
Characterization of 16S rRNA methylase genes in Enterobacterales and Pseudomonas aeruginosa in Athens Metropolitan area, 2015-2016.
Eur J Clin Microbiol Infect Dis
; 40(1): 111-121, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32794063
14.
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity.
BMC Infect Dis
; 21(1): 309, 2021 Mar 31.
Article
in English
| MEDLINE | ID: mdl-33789574
15.
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms.
Clin Infect Dis
; 71(10): 2599-2607, 2020 12 17.
Article
in English
| MEDLINE | ID: mdl-31758195
16.
In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.
J Antimicrob Chemother
; 75(8): 2164-2172, 2020 08 01.
Article
in English
| MEDLINE | ID: mdl-32449909
17.
Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019.
Euro Surveill
; 25(3)2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31992391
18.
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Clin Infect Dis
; 69(5): 769-776, 2019 08 16.
Article
in English
| MEDLINE | ID: mdl-30462182
19.
In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
Eur J Clin Microbiol Infect Dis
; 38(6): 1143-1150, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30825054
20.
Correction to: In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
Eur J Clin Microbiol Infect Dis
; 38(6): 1151-1152, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31037478